PLx Pharma Inc. Common Stock
PLXP
PLXP was delisted on the 12th of April, 2023.
15 hedge funds and large institutions have $6.51M invested in PLx Pharma Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 4 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% less capital invested
Capital invested by funds: $6.52M → $6.51M (-$6.52K)
17% less funds holding
Funds holding: 18 → 15 (-3)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Brown Advisory
Baltimore,
Maryland
|
+$116K |
| 2 |
Renaissance Technologies
New York
|
+$12.4K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$11K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$9.18K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$20 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.87K |
| 2 |
1W
1776 Wealth
Atlanta,
Georgia
|
-$3K |
| 3 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
-$648 |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$241 |
PLXP Hedge Fund Activity: Q3 2020 in Review
15 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in PLx Pharma Inc. Common Stock (PLXP) for Q3 2020, worth a combined $6.51M — down 0.1% from $6.52M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PLXP and 1 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was Brown Advisory, opening a new position worth an estimated $116K. The largest seller was Millennium Management, cutting an estimated $3.87K.
- 15 institutional investors held PLx Pharma Inc. Common Stock (PLXP) as of Q3 2020, down from 18 in Q2 2020.
- Funds reported $6.51M of PLx Pharma Inc. Common Stock stock for Q3 2020, down 0.1% quarter-over-quarter.
- 1 fund opened new PLx Pharma Inc. Common Stock positions in Q3 2020 and 4 closed out, a net change of -3 holders.
- The largest PLx Pharma Inc. Common Stock buyer in Q3 2020 was Brown Advisory, an estimated $116K added.
- The largest PLx Pharma Inc. Common Stock seller in Q3 2020 was Millennium Management, an estimated $3.87K sold.
Based on aggregated 13F filings for Q3 2020.